help button home button Endocrine Society JCEM JCEM Call for Nominations for EIC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2007-0352
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
92/9/3689    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hainerová, I.
Right arrow Articles by Pedersen, O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hainerová, I.
Right arrow Articles by Pedersen, O.
Related Collections
Right arrow Obesity
Right arrow Neuroendocrinology and Pituitary
Right arrow Pediatric Endocrinology
The Journal of Clinical Endocrinology & Metabolism Vol. 92, No. 9 3689-3696
Copyright © 2007 by The Endocrine Society

Melanocortin 4 Receptor Mutations in Obese Czech Children: Studies of Prevalence, Phenotype Development, Weight Reduction Response, and Functional Analysis

Irena Hainerová, Lesli H. Larsen, Birgitte Holst, Marie Finková, Vojtech Hainer, Jan Lebl, Torben Hansen and Oluf Pedersen

Department of Pediatrics and Center for Research of Diabetes, Metabolism, and Nutrition (I.H., M.F.), Third Faculty of Medicine, Charles University, 100 34 Prague 10, Czech Republic; Steno Diabetes Center and Hagedorn Research Institute (L.H.L., T.H., O.P.), Gentofte, DK-2820 Copenhagen, Denmark; Department of Pharmacology (B.H.), University of Copenhagen, DK-2200 Copenhagen, Denmark; Obesity Management Center (V.H.), Institute of Endocrinology, 116 94 Prague, Czech Republic; Department of Pediatrics (J.L.), Second Faculty of Medicine, Charles University, 15006 Prague 5, Czech Republic; Danish Epidemiology Science Center (L.H.L.), Institute of Preventive Medicine, Copenhagen University Hospital, DK-1357 Copenhagen, Denmark; and Faculty of Health (O.P.), University of Aarhus, DK-8000 C Aarhus, Denmark

Address all correspondence and requests for reprints to: Irena Hainerová, M.D., Department of Pediatrics, Srobárova 50, 100 34 Prague 10, Czech Republic. E-mail: ihainer{at}hotmail.com.

Background: Mutations in the melanocortin 4 receptor gene (MC4R) represent the most common known cause of monogenic human obesity.

Aims: The aims of this study were the following: 1) to estimate the prevalence of MC4R mutations in obese Czech children; 2) to evaluate phenotypic features of the mutation carriers; 3) to compare weight, height, and body mass index of MC4R mutation carriers with noncarriers in longitudinal studies; 4) to determine the effect of a weight management program among MC4R mutation carriers; and 5) to perform a functional analysis of a novel variant.

Subjects and Methods: We analyzed the coding region of MC4R in a cohort of 289 Czech children and adolescents with early-onset obesity by direct sequencing. Information on weight, height, body mass index, baseline biochemical data, and a weight loss follow-up study was obtained. In vitro functional analysis of one novel variant was performed.

Results: We identified six different mutations in seven probands: one novel missense mutation Cys84Arg and five previously reported variants, Arg7Cys, Ser19fsdelA, Phe51Leu, Ser127Leu, and Gly181Asp. The Gly181Asp variant was detected in one homozygous carrier from unrelated parents. None of the mutation carriers fulfilled the MC4R syndrome criteria. A comparison of anthropometrics in mutation carriers and noncarriers during 13 yr of follow-up did not reveal any significant differences. MC4R mutation carriers exhibited a similar ability to lose weight as obese noncarriers. The novel variant Cys84Arg showed a significant reduction in cAMP signal properties of the MC4R.

Conclusions: Among obese Czech children, we found a prevalence of 2.4% of MC4R homozygous and heterozygous mutations and showed a similar response to diet management of MC4R mutation carriers and noncarriers.




This article has been cited by other articles:


Home page
Diabetes CareHome page
V. Hainer, H. Toplak, and A. Mitrakou
Treatment Modalities of Obesity: What fits whom?
Diabetes Care, February 1, 2008; 31(Supplement_2): S269 - S277.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2007 by The Endocrine Society